Does Effexor deplete the same nutrients as SSRIs?

Largely yes — sodium, folate, B6, and melatonin are depleted by both drug classes through the shared serotonin reuptake inhibition mechanism. However, venlafaxine's additional norepinephrine reuptake inhibition above 150 mg adds magnesium depletion through COMT enzyme demand and amplifies B-vitamin requirements by doubling the neurotransmitter synthesis load. CTD catalogs 59 gene interactions for venlafaxine, and this dual mechanism creates a more comprehensive depletion profile than SSRIs alone.

Why is venlafaxine withdrawal so severe?

Venlafaxine has the shortest half-life of any commonly prescribed antidepressant at just 5 hours. Missing a single dose can trigger brain zaps, dizziness, nausea, and emotional instability within hours. B-vitamin and magnesium depletion compound withdrawal severity because these cofactors are needed for neurotransmitter production and nervous system stability. Across 1,213 PubMed-indexed articles on venlafaxine, discontinuation syndrome is among the most consistently reported adverse effects.

Can venlafaxine cause dangerously low sodium?

Yes. Venlafaxine carries the highest SIADH risk of any antidepressant because both serotonergic and noradrenergic pathways stimulate ADH release, while norepinephrine also affects renal sodium handling. FAERS data across 41,982 reports shows an 85.7% serious adverse event rate. Risk factors: age over 65, female sex, low body weight, concurrent diuretics. Sodium should be tested at baseline and 2 weeks after starting, with immediate evaluation if confusion or persistent headaches develop.

What supplements help with Effexor side effects?

Priority supplements for venlafaxine users: activated B-complex including P5P (25-50 mg B6), L-methylfolate (7.5-15 mg), and methylcobalamin (1,000 mcg B12) to support dual neurotransmitter synthesis demand. Magnesium glycinate (200-400 mg in the evening) addresses COMT enzyme demand and improves sleep. Low-dose melatonin (0.3-0.5 mg at bedtime) replaces the disrupted pineal hormone. Always inform your prescriber about supplements.

Why does Effexor raise blood pressure?

Venlafaxine is the only commonly prescribed antidepressant that raises blood pressure, and this effect traces to its norepinephrine reuptake inhibition. Blocked norepinephrine clearance increases sympathetic nervous system tone, constricting blood vessels and raising cardiac output. The effect is dose-dependent and intensifies above 150 mg where the SNRI mechanism fully activates. Blood pressure monitoring (target below 130/80 mmHg) is recommended, as elevation also correlates with accelerated magnesium depletion.

Why does Effexor cause night sweats?

Venlafaxine's norepinephrine reuptake inhibition stimulates sweat glands through increased sympathetic nervous system activation. Night sweats affect 10-20% of Effexor users and are dose-dependent, intensifying above 150 mg where the noradrenergic mechanism engages. While not a direct nutrient depletion effect, mineral losses through excessive perspiration — including magnesium, zinc, and potassium — compound the medication's direct depletion of these electrolytes and minerals.

4 Nutrients Affected · Based on CTD Molecular Database

What Does Venlafaxine Deplete? 4 Nutrients Affected

Venlafaxine (Effexor, Effexor XR) depletes sodium through SIADH at the highest rate of any antidepressant, B-complex vitamins through increased neurotransmitter synthesis demand, magnesium through norepinephrine pathway activation, and melatonin through disrupted pineal conversion. Prescribed approximately 15 million times annually, venlafaxine has a uniquely short 5-hour half-life that creates the worst withdrawal syndrome of any antidepressant. The Comparative Toxicogenomics Database catalogs 59 gene interactions with 1,972 disease associations and 106 curated entries, while 127 randomized controlled trials across 117,864 patients document its efficacy and adverse effects.

Taking this medication? Check what it depletesFree, 10 seconds →

Data sourced from CTD, ChEMBL, FAERS, PubMed, PharmGKB. How we verify this data →

Sources verified as of April 2026

[01]

Depletions Overview

Sodium

High

Venlafaxine carries the highest SIADH risk of any antidepressant, exceeding even SSRIs, because both serotonergic and noradrenergic pathways independently stimulate ADH release from the posterior pituitary while norepinephrine also affects renal tubular sodium reabsorption. This dual mechanism increases water retention and dilutes blood sodium more aggressively than single-target antidepressants. According to CTD data documenting 59 gene interactions and 1,972 disease associations, hyponatremia is among the most clinically dangerous venlafaxine adverse effects, with severe cases below 120 mEq/L occurring within 2-3 weeks of initiation.

Onset: 1-4 weeks

B-Complex Vitamins

Moderate-High

Venlafaxine's dual reuptake inhibition of both serotonin (SLC6A4) and norepinephrine (SLC6A2) dramatically increases metabolic demand for B6 (as P5P cofactor for aromatic L-amino acid decarboxylase), folate (for BH4 tetrahydrobiopterin synthesis feeding tryptophan hydroxylase), and B12 (for methylation reactions regenerating methionine from homocysteine). This dose-dependent mechanism means B-vitamin demand escalates above 150 mg where norepinephrine reuptake inhibition activates: below 150 mg venlafaxine acts primarily as an SSRI, above 150 mg the dual SNRI mechanism doubles the cofactor requirement across two neurotransmitter synthesis pathways.

Onset: 4-8 weeks

Persistent fatigue and low energy despite adequate sleepBrain fog and difficulty concentrating throughout the dayMood instability and emotional reactivity between dosesTingling or numbness in the hands and feet from peripheral neuropathyPoor sleep quality despite feeling physically exhausted

Magnesium

Moderate

The norepinephrine reuptake inhibition unique to SNRIs activates the sympathetic nervous system stress response, which increases magnesium utilization as a cofactor for catechol-O-methyltransferase (COMT) — the enzyme that metabolizes norepinephrine. Elevated norepinephrine turnover from venlafaxine's dual mechanism consumes intracellular magnesium faster than dietary replacement can maintain stores. Night sweats, affecting 10-20% of venlafaxine users, further compound magnesium losses through perspiration. Additionally, venlafaxine's noradrenergic blood pressure elevation increases renal magnesium excretion through pressure-natriuresis.

Onset: 6-12 weeks

Muscle tension and tightness especially in the neck and shouldersHeadaches with a tension-type pattern radiating from the neckIncreased anxiety and restlessness that feels distinct from the underlying disorderDifficulty falling asleep despite physical and mental tirednessHeart palpitations and awareness of heartbeat especially at rest

Melatonin

Moderate

Serotonin is the direct biochemical precursor to melatonin in the pineal gland. Venlafaxine's serotonin reuptake inhibition alters intracellular serotonin dynamics, disrupting the N-acetyltransferase conversion that produces melatonin each night. Across 1,213 PubMed-indexed articles on venlafaxine, insomnia is consistently among the most reported side effects. The melatonin disruption begins through the same serotonergic mechanism as SSRIs, but venlafaxine's additional noradrenergic activation further interferes with sleep architecture by increasing arousal signals that counteract melatonin's sleep-promoting effects.

Onset: 1-4 weeks

Difficulty falling asleep despite feeling physically tiredWaking at 2-4 AM unable to return to sleepVivid or disturbing dreams disrupting overall sleep qualityFeeling wired and alert at bedtime despite daytime exhaustionLoss of natural sleepiness signals that used to cue bedtime

Wondering about YOUR specific medications?

Check free — no signup, 10 seconds →

[02]

How It Causes Depletions

Venlafaxine is prescribed approximately 15 million times annually in the United States under the brand names Effexor and Effexor XR for major depressive disorder, generalized anxiety disorder, social anxiety disorder, and panic disorder. According to ChEMBL mechanism-of-action data, venlafaxine inhibits both the serotonin transporter (SLC6A4) and the norepinephrine transporter (SLC6A2), with a dose-dependent mechanism that makes it functionally an SSRI below 150 mg and a full SNRI above 150 mg. Venlafaxine has 45% oral bioavailability, reaches peak plasma concentration at 2 hours, carries only 27% protein binding, and has a critically short elimination half-life of just 5 hours. This 5-hour half-life is the shortest of any commonly prescribed antidepressant and directly causes the worst withdrawal syndrome in the class — brain zaps, dizziness, nausea, and emotional instability can begin within hours of a single missed dose. The four nutrient depletions stem from this dual reuptake mechanism: sodium depletion from enhanced ADH signaling, B-vitamin depletion from doubled neurotransmitter synthesis demand, magnesium depletion from noradrenergic COMT activation, and melatonin disruption from altered pineal serotonin dynamics.

The Comparative Toxicogenomics Database catalogs 59 gene interactions for venlafaxine with 1,972 disease associations and 106 curated entries. The sodium depletion mechanism is more aggressive than with SSRIs because both serotonergic and noradrenergic pathways independently stimulate ADH release. FAERS adverse event data captures 41,982 total reports for venlafaxine with an 85.7% serious adverse event rate — the highest serious event percentage among commonly prescribed antidepressants. The norepinephrine component creates a unique venlafaxine effect: dose-dependent blood pressure elevation that is not seen with SSRIs. PharmGKB pharmacogenomic annotations link venlafaxine response to genetic variants in CYP2C19, CYP2D6, ABCB1, and FKBP5 that affect metabolism and therapeutic response. CYP2D6 poor metabolizers accumulate the parent compound faster, potentially intensifying both therapeutic effects and nutrient depletion through higher sustained drug exposure.

Across 1,213 PubMed-indexed articles and 127 randomized controlled trials involving 117,864 patients, venlafaxine's evidence base is substantial for depression, anxiety, and neuropathic pain. The B-vitamin depletion mechanism operates through doubled metabolic demand: serotonin synthesis requires vitamin B6 (as pyridoxal-5-phosphate) for aromatic L-amino acid decarboxylase, folate for tetrahydrobiopterin production, and B12 for methylation cycle regeneration. When venlafaxine blocks reuptake of both serotonin and norepinephrine above 150 mg, the brain compensates by increasing synthesis of both neurotransmitters, doubling the cofactor demand compared to single-target SSRIs. Magnesium depletion is unique to the SNRI mechanism: norepinephrine is metabolized by COMT (catechol-O-methyltransferase), a magnesium-dependent enzyme. Higher noradrenergic turnover from venlafaxine consumes intracellular magnesium faster than dietary intake replenishes it, while the blood pressure-raising noradrenergic effect simultaneously increases renal magnesium excretion. This compound depletion pattern — nutrient demand increasing while excretion accelerates — makes venlafaxine's magnesium effect more aggressive than SSRIs.

[03]

Symptoms to Watch For

Confusion and difficulty thinking clearly mimicking worsening depressionPersistent headaches developing in the first weeks of treatmentNausea and decreased appetite unrelated to GI side effectsDizziness and unsteadiness when standing or walkingMuscle weakness and cramping especially in the legsPersistent fatigue and low energy despite adequate sleepBrain fog and difficulty concentrating throughout the dayMood instability and emotional reactivity between dosesTingling or numbness in the hands and feet from peripheral neuropathyPoor sleep quality despite feeling physically exhaustedMuscle tension and tightness especially in the neck and shouldersHeadaches with a tension-type pattern radiating from the neckIncreased anxiety and restlessness that feels distinct from the underlying disorderDifficulty falling asleep despite physical and mental tirednessHeart palpitations and awareness of heartbeat especially at restDifficulty falling asleep despite feeling physically tiredWaking at 2-4 AM unable to return to sleepVivid or disturbing dreams disrupting overall sleep qualityFeeling wired and alert at bedtime despite daytime exhaustionLoss of natural sleepiness signals that used to cue bedtime

Venlafaxine-induced depletions develop across different timelines: melatonin disruption and insomnia appear within weeks, sodium depletion peaks at weeks 1-4, B-vitamin demand escalates over 4-8 weeks, and magnesium stores deplete over 6-12 weeks. The symptom picture is complicated by the dose-dependent SNRI mechanism — below 150 mg the depletion profile resembles an SSRI, while above 150 mg the norepinephrine component adds magnesium depletion and amplifies B-vitamin demand. Many symptoms overlap directly with the depression and anxiety conditions Effexor is prescribed to treat.

[04]

What to Monitor

Request these at your next appointment. Check the ones you want to remember.

Serum Sodium (136-145 mEq/L)

Venlafaxine carries the highest SIADH risk of any antidepressant due to dual serotonergic and noradrenergic ADH stimulation. Check sodium at baseline and 2 weeks after starting. Elderly patients, women, those on concurrent diuretics, and individuals with low body weight are at highest risk. Sodium below 130 mEq/L causes confusion frequently misdiagnosed as worsening depression, leading to dose escalation that worsens the problem.

RBC Magnesium (5.0-6.5 mg/dL)

Serum magnesium is unreliable because only 1% of body magnesium resides in blood. RBC magnesium reflects intracellular stores and catches depletion that serum testing misses. Venlafaxine's noradrenergic mechanism depletes magnesium through COMT enzyme demand and pressure-natriuresis. Magnesium glycinate (200-400 mg in the evening) supports COMT function and improves sleep.

Active B6 (PLP) (20-50 ng/mL)

Measure pyridoxal-5-phosphate (PLP), the active coenzyme form of B6, not total pyridoxine. Most standard lab panels measure inactive pyridoxine, which can appear normal even when the active form is depleted. P5P is the direct cofactor for aromatic L-amino acid decarboxylase in both serotonin and norepinephrine synthesis — the two pathways venlafaxine targets.

Blood Pressure (<130/80 mmHg)

Venlafaxine is the only commonly prescribed antidepressant that raises blood pressure through its norepinephrine reuptake inhibition. Blood pressure elevation is dose-dependent and intensifies above 150 mg. Regular monitoring catches noradrenergic overactivation, which correlates with the intensity of magnesium depletion and the severity of night sweats, anxiety, and palpitations.

[05]

What vs Others

Name	Depletions	Potency	Notes
VenlafaxineThis drug	4 nutrients	High	Shortest half-life (5h), worst withdrawal, highest SIADH risk, raises blood pressure
Duloxetine	4 nutrients	Moderate	Same dual mechanism but longer half-life (12h) reduces withdrawal severity
Desvenlafaxine	4 nutrients	Moderate-High	Active metabolite of venlafaxine, 11h half-life, less CYP2D6 dependence
Sertraline	3 nutrients	Moderate	SSRI only, no norepinephrine effects on magnesium or blood pressure

Venlafaxine's dual SNRI mechanism creates the most aggressive nutrient depletion profile in the antidepressant class, with the additional magnesium pathway through noradrenergic COMT activation that SSRIs lack. Its critically short 5-hour half-life creates the worst withdrawal syndrome of any antidepressant — a problem amplified by B-vitamin and magnesium depletion. According to 127 randomized controlled trials across 117,864 patients, duloxetine and desvenlafaxine produce similar depletion profiles but with longer half-lives that reduce withdrawal severity. According to FAERS analysis of 41,982 reports, venlafaxine carries an 85.7% serious adverse event rate, the highest among commonly prescribed antidepressants.

[06]

Food Sources for Depleted Nutrients

Food	Amount per Serving
Nutritional yeast	4 mg B6, 18 mcg B12 per 2 tbsp
Beef liver	0.9 mg B6, 70 mcg B12 per 3 oz
Sunflower seeds	0.8 mg B6 per 1/4 cup
Spinach (cooked)	263 mcg folate per cup
Lentils (cooked)	358 mcg folate per cup

Source: USDA Food Composition Database (658,209 food nutrient entries)

[07]

FAQ

[08]

References

[1]Comparative Toxicogenomics Database (CTD): 59 venlafaxine gene interactions, 1,972 disease associations, 106 curated entries (accessed April 2026)
[2]ChEMBL Database: Venlafaxine classified as dual serotonin-norepinephrine transporter inhibitor, F=45%, T1/2=5h, PPB=27%, Tmax=2h (accessed April 2026)
[3]PharmGKB Database: Pharmacogenomic annotations linking CYP2C19, CYP2D6, ABCB1, and FKBP5 variants to venlafaxine metabolism and therapeutic response (accessed April 2026)
[4]PubMed: 1,213 indexed articles for venlafaxine; 127 randomized controlled trials across 117,864 patients (accessed April 2026)
[5]FAERS Database: 41,982 total adverse event reports for venlafaxine with 85.7% classified as serious events (accessed April 2026)

This information is generated from peer-reviewed molecular databases including the Comparative Toxicogenomics Database (CTD), ChEMBL, and indexed PubMed research. It is not medical advice. Always consult your healthcare provider before making changes to your medications or supplements. See our methodology →

SNRI Drug Class Overview

Compare nutrient depletions across all serotonin-norepinephrine reuptake inhibitors

Duloxetine Nutrient Depletions

How duloxetine compares to venlafaxine in depletion profile and withdrawal risk

Magnesium Deficiency Guide

Complete guide to magnesium testing, RBC vs serum, and repletion strategies

Check What YOUR Medications Deplete

Free. No signup. 10 seconds.

Check Now →

Contents

Check your medications

Check Free →